Biotalys NV (EBR:BTLS)

Belgium flag Belgium · Delayed Price · Currency is EUR
2.600
+0.030 (1.17%)
Feb 10, 2026, 9:24 AM CET
Market Cap96.42M -26.3%
Revenue (ttm)n/a
Net Income-14.83M
EPS-0.42
Shares Out37.52M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume44,317
Average Volume58,935
Open2.550
Previous Close2.570
Day's Range2.480 - 2.610
52-Week Range2.510 - 5.500
Beta0.86
RSI25.26
Earnings DateMar 12, 2026

About Biotalys NV

Biotalys NV, an agricultural technology company, discovers and develops protein-based biocontrol solutions in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also provides the AGROBODY Foundry technology platform, which generates protein-based crop protection products. In addition, the company develops EVOCA 1st generation, EVOCA Next generation, and BIOFUN-6 targeting botrytis, powdery mildew, and anthracnose in fruits and vegetables; BIOFUN-7 targeting leafspot disease in cowpeas and other legumes; BIOFUN... [Read more]

Sector Materials
Founded 2013
Employees 63
Stock Exchange Euronext Brussels
Ticker Symbol BTLS
Full Company Profile

Financial Performance

Financial Statements

News

Biotalys Secures EPA Approval For EVOCA, First Protein-Based Biofungicide

(RTTNews) - Biotalys (BTLS.BR) announced that the U.S. Environmental Protection Agency (EPA) has granted regulatory approval for its breakthrough biofungicide, EVOCA. Developed using the company's pro...

2 months ago - Nasdaq